<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="210134">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00351962</url>
  </required_header>
  <id_info>
    <org_study_id>20131</org_study_id>
    <nct_id>NCT00351962</nct_id>
  </id_info>
  <brief_title>Phase I/II Study of Fractionated Stereotactic Radiotherapy for Medically Inoperable Non-Small Cell Lung Cancer (NSCLC) or Metastatic Lung Tumours</brief_title>
  <official_title>Phase I/II Study of Fractionated Stereotactic Radiotherapy for Medically Inoperable Non-Small Cell Lung Cancer (NSCLC) or Metastatic Lung Tumours</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alberta Health Services</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>AHS Cancer Control Alberta</source>
  <brief_summary>
    <textblock>
      Medically inoperable lung cancer or metastatic lung tumours will be treated with
      fractionated stereotactic radiation using a schedule of 1) 12 Gy x 4 treatments or 2) 6 Gy x
      10 treatments.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2006</start_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Dose-limiting toxicity as defined by CTCAE V3 grade 4 or 5.</measure>
  </primary_outcome>
  <enrollment type="Anticipated">58</enrollment>
  <condition>Lung Neoplasms</condition>
  <condition>Lung Cancer</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Fractionated Stereotactic Radiotherapy</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  non-small cell lung cancer less than 6cm; no mediastinal or distant metastases

          -  Open to Alberta,Canada Residents

        Exclusion Criteria:

          -  tumour size greater than 6cm; inadequate pulmonary function(ie. FEV1 less than 0.8
             L), Karnofsky performance status less than 70, multiple co-morbid conditions
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Harold P Lau, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tom Baker Cancer Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Harold P Lau, MD</last_name>
    <phone>403-521-3012</phone>
  </overall_contact>
  <location>
    <facility>
      <name>Tom Baker Cancer Center</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <zip>T2N 4N2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marilyn David</last_name>
      <phone>403-521-3619</phone>
      <email>marilyn.david@albertahealthservices.ca</email>
    </contact>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>January 2012</verification_date>
  <lastchanged_date>January 18, 2012</lastchanged_date>
  <firstreceived_date>July 11, 2006</firstreceived_date>
  <keyword>lung neoplasms</keyword>
  <keyword>metastatic lung cancer</keyword>
  <keyword>stereotactic radiation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Lung Neoplasms</mesh_term>
    <mesh_term>Carcinoma, Non-Small-Cell Lung</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
